Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last kr358.60 DKK
Change Today -10.60 / -2.87%
Volume 3.0M
NOVOB On Other Exchanges
Symbol
Exchange
OTC US
Copenhagen
New York
Mexico
Frankfurt
As of 11:04 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Heath Lukatch Ph.D.

Executive Officer of San Francisco Office,Novo Nordisk A/S
AgeTotal Calculated CompensationThis person is connected to 80 board members in 9 different organizations across 18 different industries.

See Board Relationships
47--

Background*

Mr. Heath Lukatch, Ph. D., is Partner and Managing Director at TPG Biotech. He was a Partner at Novo A/S where he helped establish Novo Ventures’ San Francisco office. He was employed at the firm for nine years. Mr. Lukatch had been an Executive Officer at Novo Nordisk A/S since May 18, 2006. Mr. Lukatch joined Novo A/S in 2006. Prior to joining Novo Ventures, Mr. Lukatch was responsible for biotechnology venture investments at Piper Jaffray Ventures. From 2001 to 2006, ...

Read Full Background

Corporate Headquarters*

Novo Allé
Bagsvaerd, Capital Region of Denmark 2880

Denmark

Phone: 45 44 44 88 88
Fax: 45 44 49 05 55

Board Members Memberships*

Director
Chairman of the Board
Chairman of The Board
Director
Director
2006-Present
Chairman and Chairman of Compensation, Nominating & Governance Committee
2012-Present
Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
2014-Present
Director
2014-Present
Director

Education*

PhD
Stanford University
BA
University of California Berkeley

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVOB:DC kr358.60 DKK -10.60

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$916.0K
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
$500.0K
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.6M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVO NORDISK A/S-B, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.